China’s 2021 Healthcare Report Shows Rising Life Expectancy, Increased Medical Spending
China’s National Health Commission (NHC) released the “Healthcare Statistical Communique 2021,” revealing increased healthcare spending,...
COVID-19
Brii Biosciences Launches Anti-COVID-19 Antibody Cocktail in China
China-based Brii Biosciences Ltd (HKG: 2137) announced the commercial launch in China of the anti-COVID-19...
Ascletis Pharma Files IND Application for ASC10 with US FDA
China-based Ascletis Pharma Inc. (HKG: 1672) announced that it has filed an Investigational New Drug...
Wuhan YZY Biopharma Raises RMB 200M for Bispecific Antibodies and COVID-19 Vaccine Development
China-based Wuhan YZY Biopharma Co., Ltd has reportedly raised RMB 200 million (USD 29.8 million)...
Shionogi Files NDA for S-217622 COVID-19 Antiviral Drug in China
Japan-based Shionogi & Co., Ltd has submitted a New Drug Application (NDA) to the National...
Recbio’s R520A mRNA COVID-19 Vaccine Receives Clinical Approval in the Philippines
China-based Jiangsu Recbio Technology Co., Ltd has announced receiving clinical trial approval from the Food...
Clover Biopharmaceuticals’ SCB-2019 COVID-19 Vaccine Shows Strong Immune Response in Third Shot Study
China-based Clover Biopharmaceuticals Ltd (HKG: 2197) has published clinical data for its COVID-19 vaccine candidate...
Sinovac Biotech’s CoronaVac Receives Conditional Registration from South African Regulator
China-based Sinovac Biotech Ltd (NASDAQ: SVA) has announced that the South African Health Products Regulatory...
Joysbio Develops Rapid Test for SARS-CoV-2 Omicron Subvariants BA.4 and BA.5
China-based Joysbio (Tianjin) Biotechnology Co., Ltd. has developed a rapid test to diagnose the latest...
Kexing Pharmaceutical’s Oral COVID-19 Drug SHEN26 Accepted for Clinical Trial Review
China-based Kexing Pharmaceutical (SHA: 688136) announced that a clinical trial application for SHEN26, an oral...
Walvax’s mRNA Vaccine AWcorna Shows Superior Immune Response in Phase III Trial
Walvax Biotechnology Co., Ltd’s (SHE: 300142) mRNA vaccine against SARS-CoV-2, named AWcorna, has reached the...
Yabao Pharmaceutical’s YBSW015 Gets Australian Ethical Approval for COVID-19 Trial
China-based Yabao Pharmaceutical Group Co., Ltd (SHA: 600351) has announced that it has received clinical...
Suzhou Zelgen’s JAK Inhibitor Jacktinib Gets NMPA Green Light for COVID-19 Trial
China-based Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) has announced that it has received approval...
NHSA Releases Draft Proposals for NRDL Annual Renewal Process
The National Healthcare Security Administration (NHSA) has formulated and released draft proposals for rules covering...
Clover Biopharmaceuticals Begins Phase III Trial for COVID-19 Booster SCB-2019
China-based Clover Biopharmaceuticals Ltd (HKG: 2197) has announced the immunization of the first group of...
Latin America Accelerates COVID-19 Fight with Vaccine and Treatment Initiatives Across the Region
Latin America is ramping up its contributions to the worldwide race for COVID-19 vaccines and...
Thermo Fisher Scientific Develops Serology Test to Detect COVID-19 Antibodies in Collaboration with WuXi Diagnostics and Mayo Clinic
Thermo Fisher Scientific Inc., a titan in the US device industry and listed on the...